3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
66
Phase 1
38
Phase 1/2
13
Phase 3
10
Phase NA
6
Phase EARLY_PHASE1
1
Phase 2/3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Breast Neoplasms
40
Neoplasms
36
Prostatic Neoplasms
32
Colorectal Neoplasms
22
Carcinoma, Non-Small-Cell Lung
22
Leukemia, Myeloid, Acute
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Neoplasm Metastasis
14
Polycystic Ovary Syndrome
13
Lung Neoplasms
13
Stomach Neoplasms
12
Multiple Myeloma
11
Carcinoma, Hepatocellular
11
Recurrence
10
Pancreatic Neoplasms
10
Urinary Bladder Neoplasms
9
Lymphoma
9
Leukemia
9
Myelodysplastic Syndromes
8
Motor Activity
8
Head and Neck Neoplasms
8
Liver Neoplasms
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Esophageal Neoplasms
7
Colonic Neoplasms
7
Brain Neoplasms
7
Pain
6
Ovarian Neoplasms
6
Lymphoma, Non-Hodgkin
6
Lymphoma, Follicular
6
Interventions
Pemetrexed
1
Cisplatin
1
Carboplatin
1
ADI PEG20
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Completed
×
Mesothelioma, Malignant
×
Clear all
NCT02709512
2023-10-04
ATOMIC
Polaris Group
Phase 2/3
Completed
249 enrolled
17 charts